Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-219-0 | CAS number: 15174-47-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Comparable to OECD Guideline 474. Deficiencies were: only four animals tested per dose; bone marrow taken only once, six hours after final treatment; only 1000 erythrocytes scored per animal
Data source
Reference
- Reference Type:
- publication
- Title:
- STUDY OF ARTIFICIAL FLAVOURING SUBSTANCES FOR MUTAGENICITY IN THE SALMONELLA/MICROSOME, BASC AND MICRONUCLEUS TESTS
- Author:
- Wild, D., King, M. T., and Gocke
- Year:
- 1 983
- Bibliographic source:
- Food and Chemical Toxicology Vol 21., No. 6, pp 707-719.
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- 4 animals/dose (guideline recommends ≥ 5/sex/dose); bone marrow taken once, 6 h after final treatment (guideline recommends taking twice, 18-24 and 36-48 h after final treatment); 1000 erythrocytes scored (guideline recommends ≥ 2000)
- GLP compliance:
- not specified
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- (E)-2-methyl-3-phenylprop-2-enal
- Cas Number:
- 15174-47-7
- IUPAC Name:
- (E)-2-methyl-3-phenylprop-2-enal
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Source: ICN-K &K (Plainview, NY, USA)
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: lvanovas GmbH (Kisslegg)
- Age at study initiation: 10 to 14 weeks
- Weight at study initiation: no data available
- Assigned to test groups randomly: no data available
- Fasting period before study: no data available
- Housing: no data available
- Diet (e.g. ad libitum): standard chow (Altromin) ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data available
- Humidity (%): no data available
- Air changes (per hr): no data available
- Photoperiod (hrs dark / hrs light): no data available
IN-LIFE DATES: no data available
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: olive oil
- Justification for choice of solvent/vehicle: no data available
- Concentration of test material in vehicle: no data available
- Purity: no data available - Details on exposure:
- intraperitoneal injections
- Duration of treatment / exposure:
- single injections at 0 and 24 h
- Frequency of treatment:
- once daily, for 2 days
- Post exposure period:
- 6 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
438, 292 or 146 mg/kg bw/day
Basis:
no data
- No. of animals per sex per dose:
- probably 2 [4 animals/dose tested]
- Control animals:
- other: yes: concurrent negative controls (possibly given vehicle or no treatment)
- Positive control(s):
- no data
- Justification for choice of positive control(s): no data available
- Route of administration: no data available
- Doses / concentrations: no data available
Examinations
- Tissues and cell types examined:
- bone marrow micronucleated polychromatic erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: no data available
TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): treatment at 0 and 24 hours, sampling at 30 hours
DETAILS OF SLIDE PREPARATION: stained with May-Gruenwald and Giemsa stains. 1000 polychromatic erythrocytes analysed for each animal on coded slides.
METHOD OF ANALYSIS: no data available - Evaluation criteria:
- no data available
- Statistics:
- no data available
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- other: possibly negative control
- Negative controls validity:
- valid
- Positive controls validity:
- not specified
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: no data available
- Solubility: no data available
- Clinical signs of toxicity in test animals: no data available
- Evidence of cytotoxicity in tissue analyzed: no data available
- Rationale for exposure: no data available
- Harvest times: no data available
- High dose with and without activation: no data available
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): no data available
- Ratio of PCE/NCE (for Micronucleus assay): 1.7, 2.0 and 2.2 per thousand (for animals given 438, 292 and 146 mg/kg bw/day respectively). 2.0 per thousand for negative control.
- Appropriateness of dose levels and route: no data available
- Statistical evaluation: no data available
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
In an in vivo bone marrow micronucleus test, similar to that recommended by OECD Guideline 474, no consistent evidence of mutagenic activity was observed in mice following intraperitoneal injections of α-methylcinnamaldehyde at up to 438 mg/kg bw/day for 2 days. - Executive summary:
A publication briefly describes an in vivo micronucleus test carried out on groups of mice, conducted using a protocol similar to OECD Guideline 474.
Groups of four mice were given two intraperitoneal injections (at 0 and 24 hours) of α-methylcinnamaldehyde at 146, 292 or 438 mg/kg bw/day. Six hours after the final injection, mice were killed, and bone-marrow smears were prepared. Following fixation and staining, 1000 polychromatic erythrocytes were analysed from each animal, and the number of micronucleated polychromatic erythrocytes was recorded.
Treatment with α-methylcinnamaldehyde did not significantly induce increased numbers of micronuclei. Under the conditions of this assay, no convincing evidence of mutagenic activity was demonstrated for α-methylcinnamaldehyde.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.